A new organoid model built with human lung fragments may help us answer key questions about one of the body's first lines of defense against respiratory pathogens. In a new study, researchers at the Stanford University School of Medicine elicited virus-specific immune responses from these organoids and showed that administering a virus booster weakened subsequent infections.